ALVOGEN

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company developing and manufacturing generic, brand and biosimilar products

$315,000 Reported spend

7 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (193834), not by name.

Firms hired 1

EAST END GROUP, LLC $315,000 7 filings

Reported by year 2 years

2026 $135,000 3 filings
2025 $180,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
Commerce, Dept of (DOC) 4
U.S. Trade Representative (USTR) 4
White House Office 4

Recent filings 7 total

3TY

EAST END GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2026 · $45,000 income · posted Jul 15, 2026

View → Q2

EAST END GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $45,000 income · posted Jul 15, 2026

View → Q1

EAST END GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $45,000 income · posted Apr 14, 2026

View → Q4

EAST END GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $45,000 income · posted Jan 20, 2026

View → Q3

EAST END GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $45,000 income · posted Oct 17, 2025

View → Q2

EAST END GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $45,000 income · posted Jul 17, 2025

View → Q1

EAST END GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $45,000 income · posted Apr 17, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.